The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
Nanoparticulate systems for brain delivery of drugs.
Abstract
The blood--brain barrier (BBB) represents an insurmountable obstacle for a large number of drugs, including antibiotics, antineoplastic agents, and a variety of central nervous system (CNS)-active drugs, especially neuropeptides. One of the possibilities to overcome this barrier is a drug delivery to the brain using nanoparticles. Drugs that have successfully been transported into the brain using this carrier include the hexapeptide dalargin, the dipeptide kytorphin, loperamide, tubocurarine, the NMDA receptor antagonist MRZ 2/576, and doxorubicin. The nanoparticles may be especially helpful for the treatment of the disseminated and very aggressive brain tumors. Intravenously injected doxorubicin-loaded polysorbate 80-coated nanoparticles were able to lead to a 40% cure in rats with intracranially transplanted glioblastomas 101/8. The mechanism of the nanoparticle-mediated transport of the drugs across the blood-brain barrier at present is not fully elucidated. The most likely mechanism is endocytosis by the endothelial cells lining the brain blood capillaries. Nanoparticle-mediated drug transport to the brain depends on the overcoating of the particles with polysorbates, especially polysorbate 80. Overcoating with these materials seems to lead to the adsorption of apolipoprotein E from blood plasma onto the nanoparticle surface. The particles then seem to mimic low density lipoprotein (LDL) particles and could interact with the LDL receptor leading to their uptake by the endothelial cells. After this the drug may be released in these cells and diffuse into the brain interior or the particles may be transcytosed. Other processes such as tight junction modulation or P-glycoprotein (Pgp) inhibition also may occur. Moreover, these mechanisms may run in parallel or may be cooperative thus enabling a drug delivery to the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Brain drug delivery of small molecules using immunoliposomes
Huwyler, J., Wu, D., & Pardridge, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14164 · Cited by 660
An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro
Dehouck, M., Méresse, S., Delorme, P., Fruchart, J., & Cecchelli, R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01236.x · Cited by 548
Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
Dehouck, B., Fenart, L., Dehouck, M.-P., Pierce, A., Torpier, G., & Cecchelli, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.4.877 · Cited by 490
Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful Stimuli
Frederickson, R. C. A., Burgis, V., & Edwards, J. D. (1977) · Science · doi:10.1126/science.561998 · Cited by 379
Pardridge, W. M., Buciak, J. L., & Friden, P. M. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20567-5 · Cited by 358
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Research works printed but not linked: 6
- Kreuter, 1994, Nanoparticles, Vol. 10, 165
- Alyautdin, 1995, Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles, Eur. J. Pharm. Biopharm., 41, 44
- Ramge, 2000, Polysorbate 80-coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human, bovine and murine primary brain capilary endothelial cells, Eur. J. Neuro., 12, 1935
- Steiniger, 1999, The influence of polysorbate 80-coated nanoparticles on bovine brain capillary endothelial cells in vitro, Proc. Int. Symp. Control. Rel. Bioact. Mater., 26, 789
- Fenart, 1999, Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood–brain barrier, J. Pharmacol. Exp. Ther., 291, 1017
- Cecchelli, 1997, Receptor-mediated transcytosis of blood-borne molecules through blood–brain barrier endothelial cells: Drug targeting by endogenous transport routes, Proc. Intl. Symp. Control. Rel. Bioact. Mater., 24, 221
Cited by
Sorted by citations
Items 501–600 of 1,000
Yordanov, G. G., Skrobanska, R., & Evangelatov, A. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.05.040 · Cited by 41
Mayer, F. Q., Adorne, M. D., Bender, E. A., de Carvalho, T. G., Dilda, A. C., Beck, R. C. R., Guterres, S. S., Giugliani, R., Matte, Ú. D. S., & Pohlmann, A. R. (2014) · Pharmaceutical Research · doi:10.1007/s11095-014-1508-y · Cited by 41
Han, Z., Conley, S. M., & Naash, M. I. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6916 · Cited by 40
Jalali, N., Moztarzadeh, F., Mozafari, M., Asgari, S., Motevalian, M., & Alhosseini, S. N. (2011) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2011.10.012 · Cited by 40
Esposito, E., Cortesi, R., Drechsler, M., Fan, J., Fu, B. M., Calderan, L., Mannucci, S., Boschi, F., & Nastruzzi, C. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.011 · Cited by 41
Evaluation of potential environmental toxicity of polymeric nanomaterials and surfactants
Hering, I., Eilebrecht, E., Parnham, M. J., Günday-Türeli, N., Türeli, A. E., Weiler, M., Schäfers, C., Fenske, M., & Wacker, M. G. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103353 · Cited by 41
Maqsood, S., Din, F. U., Khan, S. U., Elahi, E., Ali, Z., Jamshaid, H., Zeb, A., Nadeem, T., Ahmed, W., Khan, S., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121198 · Cited by 40
Potential of polymeric nanoparticles in AIDS treatment and prevention
Khalil, N. M., Carraro, E., Cótica, L. F., & Mainardes, R. M. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.543673 · Cited by 40
Pompeu, L. D., Viana, A. R., Fernandes, L. D. S., & da Silva, W. L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123730 · Cited by 39
Role of engineered nanocarriers for axon regeneration and guidance: Current status and future trends
GhoshMitra, S., Diercks, D. R., Mills, N., Hynds, D. L., & Ghosh, S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.013 · Cited by 39
Ćurić, A., Möschwitzer, J. P., & Fricker, G. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.014 · Cited by 39
Togashi, T., Takami, S., Kawakami, K., Yamamoto, H., Naka, T., Sato, K., Abe, K., & Adschiri, T. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm30325f · Cited by 40
In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms
Kim, Y. S., Kong, S. D., Chen, L.-H., Pisanic, T. R., Jin, S., & Shubayev, V. I. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.05.002 · Cited by 39
Oberd√∂rster, G., M√∂ller, W., Semmler‐Behnke, M., & Kreyling, W. G. (2006) · Informa Healthcare eBooks · doi:10.1201/9781420003147.ch3 · Cited by 40
Muthu, M. S., Sahu, A. K., Sonali, Abdulla, A., Kaklotar, D., Rajesh, C. V., Singh, S. K., & Pandey, B. L. (2014) · Drug Delivery · doi:10.3109/10717544.2014.909907 · Cited by 38
Kuo, Y., & Lee, C. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24388 · Cited by 39
Lee, M. R., & Jayant, R. D. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2959-y · Cited by 39
Wang, M., Wang, C., Li, H., Du, Y., Tao, W., Ye, S., & He, Y. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9428-3 · Cited by 38
Applications of polymeric nanoparticles in drug delivery for glioblastoma
Liu, S., Tan, B., Wang, F., & Yu, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1519479 · Cited by 38
Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system
Scarpa, M., Bellettato, C. M., Lampe, C., & Begley, D. J. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.12.001 · Cited by 40
Epigenetics of Alzheimer's Disease and Frontotemporal Dementia
Veerappan, C. S., Sleiman, S. F., & Coppola, G. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0219-0 · Cited by 38
Kuo, Y., & Chen, H.-H. (2010) · Journal of drug targeting · doi:10.3109/10611860903494245 · Cited by 37
Liu, Y., Ma, Y., Xu, J., Chen, Y., Xie, J., Yue, P., Zheng, Q., & Ming, Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.10.009 · Cited by 38
Co-Encapsulation and Co-Delivery of Peptide Drugs via Polymeric Nanoparticles
Kim, M. R., Teng, F., Zhang, Q., Chan, H. Y. E., & Chau, Y. (2019) · Polymers · doi:10.3390/polym11020288 · Cited by 37
Ammulu, M. A., Konduri, V. V., Ajay Kumar, G., Mangamuri, U. K., & Sudhakar, P. (2020) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-020-00033-x · Cited by 38
Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS
Sarma, A., & Das, M. K. (2020) · Molecular Biomedicine · doi:10.1186/s43556-020-00019-8 · Cited by 39
Various drug delivery approaches to the central nervous system
Pasha, S., & Gupta, K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903405581 · Cited by 36
Shubar, H. M., Dunay, I. R., Lachenmaier, S., Dathe, M., Bushrab, F. N., Mauludın, R., Müller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2009) · Journal of drug targeting · doi:10.1080/10611860902718680 · Cited by 37
Sathler, P., Lourenço, A., Rodrigues, C., da Silva, L. C. R. P., Cabral, L., Jordão, A. K., Cunha, A., Vieira, M., Ferreira, V., Carvalho-Pinto, C., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.05.009 · Cited by 36
Ingallina, C., Rinaldi, F., Bogni, A., Ponti, J., Passeri, D., Reggente, M., Rossi, M., Kinsner‐Ovaskainen, A., Méhn, D., Rossi, F., et al. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.08.002 · Cited by 36
Kırımlıoğlu, G. Y., Menceloǵlu, Y. Z., Erol, K., & Yazan, Y. (2016) · Journal of Microencapsulation · doi:10.1080/02652048.2016.1234515 · Cited by 35
Naserzadeh, P., Esfeh, F. A., Kaviani, M., Ashtari, K., Kheirbakhsh, R., Salimi, A., & Pourahmad, J. (2017) · Cutaneous and Ocular Toxicology · doi:10.1080/15569527.2017.1363227 · Cited by 36
Han, L., Yuan, B., Shimada, R., Hayashi, H., Si, N., Zhao, H., Bian, B., & Takagi, N. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4567 · Cited by 36
Monge, M., Fornaguera, C., Quero, C., Dols-Pérez, A., Calderó, G., Grijalvo, S., García, M. J. N., Rodríguez‐Abreu, C., & Solans, C. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.09.003 · Cited by 37
Transport of a Caspase Inhibitor Across the Blood–Brain Barrier by Chitosan Nanoparticles
Yemişçi, M., Özdemir, Y., Caban-Toktas, S., Bodur, E., Çapan, Y., & Dalkara, T. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00013-6 · Cited by 36
Niwa, Y., & Iwai, N. (2007) · Circulation Journal · doi:10.1253/circj.71.437 · Cited by 36
Brain specific delivery of pegylated indinavir submicron lipid emulsions
Kandadi, P., Syed, M. A., Goparaboina, S., & Veerabrahma, K. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.01.008 · Cited by 36
Huang, Y., Gao, J., Chen, J., & Liang, W. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.03.014 · Cited by 36
Choi, S. H., Yoon, J. J., & Park, T. G. (2002) · Journal of Colloid and Interface Science · doi:10.1006/jcis.2002.8427 · Cited by 36
Iron chelators as therapeutic iron depletion agents
Birch, N. W., Wang, X., & Chong, H. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.11.1533 · Cited by 36
Girotra, P., & Singh, S. K. (2016) · AAPS PharmSciTech · doi:10.1208/s12249-016-0532-0 · Cited by 36
Alahri, M. B., Ibrahim, A. J., Barani, M., Arkaban, H., Shadman, S. M., Salarpour, S., Zarrintaj, P., Jaberi, J., & Jalil, A. T. (2023) · Molecules · doi:10.3390/molecules28020841 · Cited by 37
Drug Delivery Using Nanocarriers: Indian Perspective
Gupta, S., & Kumar, P. (2012) · Proceedings of the National Academy of Sciences India Section B Biological Sciences · doi:10.1007/s40011-012-0080-7 · Cited by 36
Kuo, Y., & Yu, H.-W. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.06.037 · Cited by 35
Raut, S., Kirthivasan, B., Bommana, M. M., Squillante, E., & Sadoqi, M. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/39/395102 · Cited by 35
Strategies for enhanced drug delivery to the central nervous system
Nagappa, A., & Dwibhashyam, V. S. N. M. (2008) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.41446 · Cited by 35
A journey through the emergence of nanomedicines with poly(alkylcyanoacrylate) based nanoparticles
Vauthier, C. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1588280 · Cited by 37
Glymphatic System and Subsidiary Pathways Drive Nanoparticles Away from the Brain
Liu, R., Jia, W., Wang, Y., Hu, C., Yu, W., Huang, Y., Wang, L., & Gao, H. (2022) · Research · doi:10.34133/2022/9847612 · Cited by 36
Colloidal systems for CNS drug delivery
Costantino, L., Tosi, G., Ruozi, B., Bondioli, L., Vandelli, M. A., & Forni, F. (2009) · Progress in brain research · doi:10.1016/s0079-6123(08)80003-9 · Cited by 35
Nanotechnologies in Drug Delivery - An Industrial Perspective
Bazile, D. (2014) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(14)50002-0 · Cited by 34
Poinern, G. E. J., Shackleton, Mamum, & Fawcett (2011) · Nanotechnology Science and Applications · doi:10.2147/nsa.s13913 · Cited by 34
Hu, X., Yang, F., Liao, Y., Lin, L., & Zhang, L. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1233590 · Cited by 34
Nanotherapeutic strategies for the treatment of neurodegenerative diseases
Huang, M., Gu, X. Q., & Gao, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814001-7.00013-5 · Cited by 34
Aghaie, T., Jazayeri, M. H., Avan, A., Anissian, A., & Salari, A. (2019) · IUBMB Life · doi:10.1002/iub.2045 · Cited by 35
Recent Trend of Ultrasound-Mediated Nanoparticle Delivery for Brain Imaging and Treatment
Jo, S., Sun, I., Ahn, C., Lee, S., & Kim, K. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c22803 · Cited by 34
Changes in target ability of nanoparticles due to protein corona composition and disease state
Xu, W., Xu, M., Xiao, Y., Yu, L., Xie, H., Jiang, X., Chen, M., Gao, H., & Wang, L. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.03.002 · Cited by 34
Reorganization of lipid nanocapsules at air–water interface
Minkov, I. L., Ivanova, T., Panaiotov, I., Proust, J. E., & Saulnier, P. (2005) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2005.07.001 · Cited by 34
Yordanov, G. G., Skrobanska, R., & Evangelatov, A. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.11.029 · Cited by 34
Mustapić, M., Hossain, M. S. A., Horvat, J., Wagner, P. W., Mitchell, D. R. G., Kim, J. H., Alıcı, G., Nakayama, Y., & Martinac, B. (2015) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2015.12.032 · Cited by 33
Vecchione, R., Pitingolo, G., Guarnieri, D., Falanga, A. P., & Netti, P. A. (2016) · Biofabrication · doi:10.1088/1758-5090/8/2/025005 · Cited by 33
Biological Voyage of Solid Lipid nanoparticles: A Proficient Carrier in Nanomedicine
Ali, H., & Singh, S. K. (2016) · Therapeutic Delivery · doi:10.4155/tde-2016-0038 · Cited by 33
PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen
Lozoya-Agulló, I., Araújo, F., González‐Álvarez, I., Merino‐Sanjuán, M., González‐Álvarez, M., Bermejo, M., & Sarmento, B. F. C. C. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.12.009 · Cited by 35
Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection
Tao, X., Mao, S., Zhang, Q., Yu, H., Li, Y., He, X., Yang, S., Zhang, Z., Yi, Z., Song, Y., et al. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03584-1 · Cited by 33
Thammasit, P., Tharinjaroen, C. S., Tragoolpua, Y., Rickerts, V., Georgieva, R. T., Bäumler, H., & Tragoolpua, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723727 · Cited by 33
Qu, K., Zhao, L., Luo, X., Zhang, C., Hou, P., Bi, K., & Chen, X. (2014) · Journal of Chromatography B · doi:10.1016/j.jchromb.2014.03.032 · Cited by 34
New non-oral drug delivery systems for Parkinson's disease treatment
Md, S., Haque, S., Sahni, J. K., Baboota, S., & Ali, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.556616 · Cited by 33
Antidepressant and cognitive activities of intranasal piperine-encapsulated liposomes
Priprem, A., Chonpathompikunlert, P., Sutthiparinyanont, S., & Wattanathorn, J. (2011) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2011.22017 · Cited by 33
Moin, A., Rizvi, S. M. D., Hussain, T., Gowda, D. V., Subaiea, G. M., Elsayed, M. M. A., Ansari, M., Alanazi, A. S., & Yadav, V. K. (2021) · Life · doi:10.3390/life11050421 · Cited by 32
Systems‐level thinking for nanoparticle‐mediated therapeutic delivery to neurological diseases
Curtis, C., Zhang, M., Liao, R., Wood, T. R., & Nance, E. A. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1422 · Cited by 32
Solid Lipid Nanoparticles for Targeted Brain Drug Delivery
Patel, S. G., Patel, M. D., Patel, A. J., Chougule, M. B., & Choudhury, H. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00008-7 · Cited by 32
Kuo, Y., Ng, I.-W., & Rajesh, R. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112233 · Cited by 32
Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion
Shi, S., Chen, H., Lin, X., & Tang, X. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.09.025 · Cited by 32
Yordanov, G. G., & Dushkin, C. D. (2010) · Colloid & Polymer Science · doi:10.1007/s00396-010-2226-6 · Cited by 32
The role of peptides in blood‐brain barrier nanotechnology
Teixidò, M., & Giralt, E. (2007) · Journal of Peptide Science · doi:10.1002/psc.983 · Cited by 32
Delivery strategies for antiparasitics
Kayser, O., & Kiderlen, A. F. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.2.197 · Cited by 32
Inorganic nanobiomaterial drug carriers for medicine
Singh, R. K., & Kim, H. (2013) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-013-1092-y · Cited by 31
Kong, W. M., Mohamed, Z., Alshawsh, M. A., & Chik, Z. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.05.020 · Cited by 31
Hu, Y., Hu, X., Lu, Y., Shi, S., Yang, D., & Yao, T. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00508 · Cited by 34
Yu, S., Duan, M., Sun, J., Jiang, H., Zhao, J., Tong, C., Pang, J., & Wu, C. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.089 · Cited by 31
Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery
Cui, L., Wang, Y., Liang, M., Chu, X., Fu, S., Gao, C., Liu, Q., Gong, W., Yang, M., Li, Z., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1519002 · Cited by 31
Nanotechnology in medical applications: possible risks for human health
de Jong, W., Roszek, B., & Re, G. (2005) · Rivm Repository (Netherlands National Institute for Public Health and the Environment) · Cited by 31
Zhao, X., Cheng, J., Gui, S., Jiang, M., Qi, D., Huang, J., Fu, L., Liu, S., Ma, Y., Shi, J., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c00502 · Cited by 30
Li, C., Li, S., Tu, T., Qi, X., Xiong, Y., Du, S., Shen, Y., Tu, J., & Sun, C. (2015) · Polymer Chemistry · doi:10.1039/c4py01422g · Cited by 30
Perspectives on Nanodelivery to the Brain: Prerequisites for Successful Brain Treatment
Hu, Y., & Hammarlund‐Udenaes, M. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00881 · Cited by 30
González, L. F., Bevilacqua, L. E., & Naves, R. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122055 · Cited by 31
Wanjale, M. V., Jaikumar, V. S., Sivakumar, K., Paul, R. A., James, J., & Kumar, G. V. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s348559 · Cited by 30
3-Hydroxypyridinone Derivatives as Metal-Sequestering Agents for Therapeutic Use
Santos, M. A., & Chaves, S. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.14.162 · Cited by 29
Preparation and Cytotoxicity of Poly(Methyl Methacrylate) Nanoparticles for Drug Encapsulation
Mendes, A. N., Hubber, I., Siqueira, M., Barbosa, G. M., Moreira, D. D. L., Holandino, C., Pinto, J. C., & Nele, M. (2012) · Macromolecular Symposia · doi:10.1002/masy.201100248 · Cited by 30
Entrapment of Bioactive Molecules in Poly (Alkylcyanoacrylate) Nanoparticles
Krauel, K., Pitaksuteepong, T., Davies, N. M., & Rades, T. (2004) · American Journal of Drug Delivery · doi:10.2165/00137696-200402040-00005 · Cited by 30
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells
Scialabba, C., Rocco, F., Licciardi, M., Pitarresi, G. L., Ceruti, M., & Giammona, G. (2012) · Drug Delivery · doi:10.3109/10717544.2012.714813 · Cited by 30
Functionalized Carbon Nanomaterials Derived from Carbohydrates
Jagadeesan, D., & Eswaramoorthy, M. (2010) · Chemistry - An Asian Journal · doi:10.1002/asia.200900275 · Cited by 30
Hyaluronate Nanoparticles as a Delivery System to Carry Neuroglobin to the Brain after Stroke
Blanco, S., Peralta, S., Morales, M. E., Martínez‐Lara, E., Pedrajas, J. R., Castán, H., Peinado, M. Á., & Ruiz, M. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010040 · Cited by 29
Kiyaseh, M., Andalib, S., Danafar, H., Rostamizadeh, K., & Sharafi, A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119546 · Cited by 29
Sommonte, F., Arduino, I., Racaniello, G. F., Lopalco, A., Lopedota, A., & Denora, N. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.08.029 · Cited by 29
Nanoparticles influence pathophysiology of spinal cord injury and repair
Sharma, H. S., Muresanu, D. F., Sharma, A., Patnaik, R., & Lafuente, J. V. (2009) · Progress in brain research · doi:10.1016/s0079-6123(08)80009-x · Cited by 29
Song, M., Guo, D., Pan, C., Jiang, H., Chen, C., Zhang, R., Gu, Z., & Wang, X. (2008) · Nanotechnology · doi:10.1088/0957-4484/19/16/165102 · Cited by 29
Introduction to Nanotechnology
Gordon, A. T., Lutz, G. E., Boninger, M. L., & Cooper, R. A. (2007) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e318031ee1a · Cited by 28
Patierno, S., Zellalem, W., Ho, A., Parsons, C. G., Lloyd, K. C. K., Tonini, M., & Sternini, C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.042 · Cited by 29
Mollaamin, F., Najafi, F., Khaleghian, M., Hadad, B. K., & Monajjemi, M. (2011) · Fullerenes Nanotubes and Carbon Nanostructures · doi:10.1080/1536383x.2010.504956 · Cited by 28
Kim, S. S., Rait, A. S., Garrido-Sanabria, E. R., Pirollo, K. F., Harford, J. B., & Chang, E. H. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.10.003 · Cited by 28
Metadata
- Authors
- Kreuter, J.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Kreuter, Jörg
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 47
- Issue
- 1
- Pages
- 65-81
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2072229818
- Cited by
- 1,107
- References
- 50
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 26 · 2023: 39 · 2022: 32 · 2021: 43 · 2020: 47 · 2019: 40 · 2018: 47 · 2017: 53 · 2016: 63 · 2015: 57 · 2014: 55 · 2013: 65 · 2012: 76
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Drug Delivery Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, nanoparticle drug delivery, brain drug delivery, apolipoprotein E, glioblastoma, doxorubicin, neuropeptides, P-glycoprotein inhibition, tight junction modulation, transcytosis, central nervous system drugs
- MeSH terms
- Animals, Antineoplastic Agents, Blood-Brain Barrier, Brain, Brain Neoplasms, Capsules, Cells, Cultured, Doxorubicin, Drug Carriers, Endothelium, Vascular, Humans, Male, Polysorbates, Surface-Active Agents, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review